[144] CNO Financial Group, Inc. SEC Filing

Rhea-AI Filing Summary

A shareholder of CNO (symbol CNO) filed a Form 144 notice indicating an intention to sell 31,430 shares of CNO common stock through Morgan Stanley Smith Barney LLC on the NYSE. The filing lists an aggregate market value of 1,256,222.53 for the shares to be sold, compared with 95,353,512 shares of common stock outstanding. The shares come from restricted stock acquired on 03/25/2022 and performance shares acquired on 02/14/2023, both issued by the company and marked as not involving separate cash payment. The seller also represents that they are not aware of any undisclosed material adverse information about CNO’s operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	31430	1256222.53	95353512	11/20/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/25/2022	Restricted Stock	ISSUER			24065	03/25/2022	Not Applicable
Common	02/14/2023	Performance Shares	ISSUER			7365	02/14/2023	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the CNO Form 144 filing disclose?

The Form 144 filing for CNO (symbol CNO) discloses a shareholder’s intent to sell 31,430 shares of CNO common stock, with an aggregate market value of 1,256,222.53, on the NYSE.

How many CNO shares are outstanding according to this Form 144?

The notice states that there are 95,353,512 shares of CNO common stock outstanding, providing context for the planned sale of 31,430 shares.

What is the planned timing and exchange for the CNO share sale?

The Form 144 lists an approximate sale date of 11/20/2025, with the NYSE named as the securities exchange where the CNO common stock is expected to be sold.

Which broker is handling the CNO Form 144 share sale?

The filing identifies Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, as the broker for the 31,430-share CNO sale.

What is the origin of the CNO shares being sold under Form 144?

The securities to be sold are restricted stock acquired on 03/25/2022 in the amount of 24,065 shares and performance shares acquired on 02/14/2023 in the amount of 7,365 shares, both from the issuer.

Does the CNO Form 144 include any representation about undisclosed information?

Yes. By signing the notice, the selling person represents that they do not know any material adverse information about CNO’s current or prospective operations that has not been publicly disclosed.